cervical intraepithelial neoplasia

Type: Keyphrase
Name: cervical intraepithelial neoplasia
First reported Jul 31 2014 - Updated Jul 31 2014 - 1 reports

Sustained efficacy, immunogenicity, and safety for GlaxoSmithKline's HPV vaccine

PUBLIC RELEASE DATE: 31-Jul-2014A long-term follow-up study (HPV-023; NCT00518336) shows the sustained efficacy, immunogenicity and safety of GlaxoSmithKline's human papilloma virus (HPV) vaccine Cervarix. Women vaccinated with the HPV-16/18 AS04-adjuvanted ... [Published EurekAlert! - Jul 31 2014]
First reported Jul 28 2014 - Updated Jul 28 2014 - 1 reports

Findings from Affiliated Hospital 2 Provide New Insights into Cervical Intraepithelial Neoplasia (Pregnancy Outcome after the Treatment of Loop...

Findings from Affiliated Hospital 2 Provide New Insights into Cervical Intraepithelial Neoplasia (Pregnancy Outcome after the Treatment of Loop Electrosurgical Excision Procedure or Cold-Knife Conization for Cervical Intraepithelial Neoplasia)By a News ... [Published Pharmacy Choice - Jul 28 2014]
First reported Jul 27 2014 - Updated Jul 27 2014 - 1 reports

New plans for hemophilia patients

Clearing cells to preventcervical cancerA study describes a novel approach to preventing cervical cancer based on findings showing successful reduction in the risk of cervical cancer after removal of a discrete population of cells in the cervix.The findings ... [Published Iran Daily - Jul 27 2014]
First reported Jul 25 2014 - Updated Jul 25 2014 - 1 reports

Clearing Cells to Prevent Cervical Cancer

Boston, MA - A study published online in the International Journal of Cancer earlier this month describes a novel approach to preventing cervical cancer based on findings showing successful reduction in the risk of cervical cancer after removal of a discrete ... [Published Noodls - Jul 25 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

Inovio Pharma's Immunotherapy for Cervical Dysplasia Meets Goal

Reuters Health InformationBy Reuters StaffJuly 24, 2014(Reuters) - Inovio Pharmaceuticals Inc announced positive results from its randomized, double-blind, placebo-controlled phase II trial of VGX-3100 in women with biopsy-proven cervical intraepithelial ... [Published General Medicine eJournal - Jul 24 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

Healthcare Review: Biogen Idec, Inovio Pharmaceuticals, Intuitive Surgical, Puma Biotechnology, Gilead Sciences

:28 U.S. stock indexes were mostly higher in early-afternoon trading Wednesday as investors weighed positive earnings from the technology industry against disappointing news from Boeing and other companies.Biotechnology stocks were among the biggest ... [Published BioMedReports - Jul 24 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 2 reports

Inovio Pharma's HPV Immunotherapy Shows Successful Results In Phase II Trial

Inovio Pharmaceuticals, Inc. (INO: Quote) Wednesday announced successful results from its randomized, double-blind, placebo-controlled phase II trial of VGX-3100 in women with biopsy-proven cervical intraepithelial neoplasia 2/3 or CIN2/3 associated with ... [Published RTTNews.com - Jul 23 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 1 reports

Findings from Affiliated Hospital 2 Provide New Insights into Cervical Intraepithelial Neoplasia (Pregnancy Outcome after the Treatment of Loop...

Findings from Affiliated Hospital 2 Provide New Insights into Cervical Intraepithelial Neoplasia (Pregnancy Outcome after the Treatment of Loop Electrosurgical Excision Procedure or Cold-Knife Conization for Cervical Intraepithelial Neoplasia)By a News ... [Published 4 Traders - Jul 23 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 1 reports

Inovio vs. Feuerstein, Round II: Biotech claims PhII success for VGX-3100

Shares of Inovio Pharmaceuticals ($INO) jumped about 20% this morning after the biotech said it hit the mark on the primary endpoint for its mid-stage study of VGX-3100, an experimental therapy designed to eliminate precancerous cervical lesions. But ... [Published FierceBiotech - Jul 23 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 2 reports

Human papillomavirus infection in Bhutan at the moment of implementation of a national HPV ...

Cervical cancer is the most common female cancer in Bhutan, the first low/middle-income country to implement a national human papillomavirus (HPV) vaccination programme.Methods: To provide a robust baseline for future evaluations of vaccine effectiveness, ... [Published 7thSpace - Jul 22 2014]
First reported Jul 16 2014 - Updated Jul 16 2014 - 1 reports

Cervical dysplasia: Is it cancer?

I had a Pap smear recently, and my doctor said the results showed cervical dysplasia. What does that mean? Is it cancer? Answers from Shannon K. Laughlin-Tommaso, M.D. MultimediaNo. Cervical dysplasia isn't cancer. The term indicates that abnormal ... [Published Mayo Clinic College of Medicine - Jul 16 2014]
First reported Jul 08 2014 - Updated Jul 08 2014 - 1 reports

Clinical Performance of the BD Onclarity HPV Assay

Thomas C. Wright Jr, MD, Mark H. Stoler, MD, Patricia M. Agreda, Gerard H. Beitman, Erin C. Gutierrez, MSc, James M. Harris, MSc, Kristopher R. Koch, Mindy Kuebler, MSc, William D. LaViers, Benjamin L. Legendre Jr, PhD, Sharon V. Leitch, PhD, ... [Published General Medicine eJournal - Jul 08 2014]

Quotes

Dr Ronald Ellis, Editor-in-Chief of HV&I, comments: "HPV vaccine has been distinctive in having achieved 100% protective efficacy in licensure trials and showing excellent persistence of protective immunity. The data in this article show persistence of protection for about one decade, which should give adolescents and young adults an increased level of confidence in taking this vaccine and being protected against the development of cervical and other cancers."
According to the news editors, the research concluded: "LEEP should be an appropriate choice for patients with CIN who want to become pregnant later in life."
An accompanying editorial, by Silvia Franceschi, MD, International Agency for Re on Cancer, suggests continuation of the work by "careful evaluation of the impact of prophylactic ablation in the framework of large screening programmes."
"This is a significant step toward providing women and their physicians a non-surgical approach to the treatment of precancerous lesions by stimulating their immune system to eliminate high risk HPV infection and induce regression of a cervical intraepithelial neoplastic process" Dr. Mark Bagarazzi, Chief Medical Officer, Inovio Pharmaceuticals, said in a news release

More Content

All (27) | News (23) | Reports (0) | Blogs (3) | Audio/Video (0) | Fact Sheets (1) | Press Releases (0)
sort by: Date | Relevance
Sustained efficacy, immunogenicity, and safety ... [Published EurekAlert! - Jul 31 2014]
Findings from Affiliated Hospital 2 Provide New... [Published Pharmacy Choice - Jul 28 2014]
New plans for hemophilia patients [Published Iran Daily - Jul 27 2014]
Clearing Cells to Prevent Cervical Cancer [Published Noodls - Jul 25 2014]
Inovio Pharma's Immunotherapy for Cervical Dysp... [Published General Medicine eJournal - Jul 24 2014]
Healthcare Review: Biogen Idec, Inovio Pharmace... [Published BioMedReports - Jul 24 2014]
Inovio's HPV Immunotherapy Hits Primary Endpoint [Published Drug Discovery and Development - Jul 23 2014]
Findings from Affiliated Hospital 2 Provide New... [Published 4 Traders - Jul 23 2014]
Inovio vs. Feuerstein, Round II: Biotech claims... [Published FierceBiotech - Jul 23 2014]
Inovio Pharma's HPV Immunotherapy Shows Success... [Published RTTNews.com - Jul 23 2014]
Inovio Pharmaceuticals : HPV Immunotherapy Achi... [Published 4 Traders - Jul 23 2014]
Inovio Pharmaceuticals HPV Immunotherapy Achiev... [Published PR Newswire: Health - Jul 23 2014]
Human papillomavirus infection in Bhutan at the... [Published 7thSpace - Jul 22 2014]
Human papillomavirus infection in Bhutan at the... [Published BMC - Jul 22 2014]
Cervical dysplasia: Is it cancer? [Published Mayo Clinic College of Medicine - Jul 16 2014]
Clinical Performance of the BD Onclarity HPV Assay [Published General Medicine eJournal - Jul 08 2014]
Measurement of Neutralizing Serum Antibodies of... [Published Plosone.org - Jul 07 2014]
Inovio Pharmaceuticals: What Investors Need to ... [Published Equities.com - Jul 07 2014]
Piper Jaffray’s Charles Duncan Addresses Pot Shots [Published Jutia Group - Jul 03 2014]
Cervical Cancer Precursors and Hormonal Contrac... [Published Plosone.org - Jul 01 2014]
Addressing Pot Shots: Charles Duncan [Published Stockboard Media Inc. - Jun 27 2014]
Is Inovio Poised to Climb, or Will It Tumble? [Published Motley Fool - Jun 26 2014]
[Correspondence] HPV-based screening for preven... [Published The Lancet - Apr 11 2014]
I do not think that study shows what you think ... [Published ScienceBlogs : Combined Feed - Apr 02 2014]
Anti-Interleukin-23 Monoclonal Antibody Guselku... [Published PR Newswire - Mar 24 2014]
Researchers suggest risk of cervical or vaginal... [Published BioPortfolio - Jan 15 2014]
Fact Sheet for Transgene [Published Able2Act - Mar 28 2008]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Inovio Pharmaceuticals HPV Immunotherapy Achiev... [Published PR Newswire: Health - Jul 23 2014]
PLYMOUTH MEETING, Pa., July 23, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced successful results from its randomized, double-blind, placebo-controlled phase II trial of VGX-3100 in women with biopsy-proven cervical ...
[Correspondence] HPV-based screening for preven... [Published The Lancet - Apr 11 2014]
The landmark follow-up study by Guglielmo Ronco and colleagues clearly demonstrates that high grade cervical intraepithelial neoplasia (CIN) is an excellent surrogate marker for invasive cervical cancer, strengthening the findings of the initial screening ...
I do not think that study shows what you think ... [Published ScienceBlogs : Combined Feed - Apr 02 2014]
Of all the cranks, quacks, antivaccinationists, and pseudoscientists that I’ve encountered (and applied a bit of not-so-Respectful Insolence to) over the years, there are a few who belong in the top tier—or, if you prefer, the bottom tier. They stick ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.